Current stock page

News

RLAY Stock News

Headlines · Sentiment · Source Context · AIQ Market Impact

HealthcareBiotechnologyScore data as of Nov 13, 2026

RLAYRelay Therapeutics, Inc.

Healthcare / Biotechnology

Low Priority

In Line With Peers

NeutralEdge 5/10
$18.09+$0.01 (+0.06%)

Latest quote

  • Momentum
    76
  • Value
    37
  • Quality
    47
  • Risk resilience
    52
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

RLAY News

Relay Therapeutics, Inc. latest headlines and updates

News Sentiment
No recent news found for RLAY
News limit reached for Free plan
Upgrade to Pro for full news feed access and deeper AI insights.
Upgrade to Pro
See how news sentiment affects the AIQ Score
Review news alongside the complete analysis workspace.

RLAY News FAQ

What is the latest RLAY stock news?

The latest RLAY stock news appears on this page when current headlines are available. Use news with price movement, sentiment, AIQ Score, and upcoming catalysts.

Why is RLAY stock moving today?

RLAY's daily move can be affected by earnings, guidance, analyst actions, sector news, macro data, or company-specific headlines. Check the current news feed and sentiment before assigning a cause.

What news is affecting RLAY stock today?

News affecting RLAY today may include earnings updates, price-target changes, product developments, regulatory items, or sector moves. Confirm whether the news is material or just short-term noise.

What should RLAY investors watch next?

RLAY investors should watch the next earnings update, analyst revisions, material company news, AIQ momentum, and risk changes. Fresh news matters most when it changes estimates or trend quality.